Skip to content

Muscle Weakness and Post-traumatic Knee OA

Muscle Weakness and Post-traumatic Knee OA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01879852
Enrollment
29
Registered
2013-06-18
Start date
2008-10-31
Completion date
2013-08-31
Last updated
2014-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniscectomy

Keywords

Quadriceps strength, Knee, Rehabilitation

Brief summary

This is a single-center, randomized, single-blind (evaluator) study. Enrolled patients had a traumatic meniscal tear and underwent meniscectomy. The study included 6 weeks (12 visits) of standard or quadriceps intensive rehabilitation. The objective of the study was to determine the effect of quadriceps intensive rehabilitation on knee function and articular cartilage.

Interventions

BEHAVIORALQuadriceps intensive strengthening

Quadriceps intensive strengthening includes high-intensity neuromuscular electrical stimulation to the quadriceps muscle for 10 minutes and overload to the the eccentric phase of quadriceps strengthening exercises.

BEHAVIORALStandard rehabilitation

Standard rehabilitation will include interventions for typical knee impairments (effusion, knee motion deficits, lower extremity muscle weakness, and gait deviations) as well as advanced rehabilitation interventions as indicated (jump and agility exercises)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

1. traumatic onset meniscal tear (i.e. specific mechanism of injury) 2. meniscectomy surgery performed within 12 months of index injury 3. meniscal tear confirmed at the time of surgery 4. subject anticipates living in close proximity to Gainesville for one year following surgery.

Exclusion criteria

1. bilateral injury 2. concomitant ligamentous injury 3. previous knee injury 4. articular cartilage defect \> Grade II on Outerbridge scale 5. patellofemoral joint pain \> 3/10 with activity 6. lower limb alignment \> 5 degrees of valgus or varus 7. contraindication to an MR examination including: a pacemaker, metal implants which are not MR compatible, pregnancy and severe claustrophobia.

Design outcomes

Primary

MeasureTime frameDescription
Change in International Knee Documentation Committee (IKDC) Subjective Knee Form ScoreBaseline (pre-surgery) to 7 weeks post-surgery (post-intervention)The IKDC is a measure of self-reported knee function and includes items related to symptoms and functional activity. Responses on the IKDC subjective knee form will be recorded on hard-copy and the summary score computed. The highest (best) possible score is 100 points and the lowest (worst) possible score is 0 points.
Change in Tibial Articular Cartilage VolumeBaseline (pre-surgery) to 1 year post-surgeryA magnetic resonance image (MRI) of the knee will be acquired and software will be used to quantify tibial articular cartilage volume.

Secondary

MeasureTime frameDescription
Single Leg Forward Hop Index7 weeks post-surgery (post-intervention)Three trials of the single leg forward hop will be collected on each side. Distance will be averaged across trials. The single leg hop index will be computed as \[(distance on the surgical side/distance on the non-surgical side) \*100\]
Change in Urinary Concentrations of C-terminal Crosslinking Telopeptide of Type II Collagen (CTX-II)Baseline (pre-surgery) to 7 weeks post-surgery (post-intervention)CTX-II is a biomarker of Type II collagen degradation. Early-morning, second void, fasting urine samples will be collected and stored. Concentrations of CTX-II will be determined with enzyme-linked immunosorbent assay, corrected for creatine concentration, and log-transformed. Creatinine concentration will also be determined with enzyme-linked immunosorbent assay.

Countries

United States

Participant flow

Pre-assignment details

29 subjects were consented to the study. During pre-surgery (baseline) testing, 2 subjects were found not to have a meniscal tear (inclusion criterion) and were withdrawn from the study. Total number of subjects meeting eligibility criteria was 27.

Participants by arm

ArmCount
Standard Rehabilitation
Standard meniscectomy rehabilitation including knee range of motion and strengthening exercises. Standard rehabilitation: Standard rehabilitation will include interventions for typical knee impairments (effusion, knee motion deficits, lower extremity muscle weakness, and gait deviations) as well as advanced rehabilitation interventions as indicated (jump and agility exercises)
14
Standard Rehabilitation + Quadriceps Intensive Strengthening
The intervention includes high-intensity neuromuscular electrical stimulation and eccentric exercises for the quadriceps muscle in addition to the standard rehabilitation protocol. Quadriceps intensive strengthening: Quadriceps intensive strengthening includes high-intensity neuromuscular electrical stimulation to the quadriceps muscle for 10 minutes and overload to the the eccentric phase of quadriceps strengthening exercises. Standard rehabilitation: Standard rehabilitation will include interventions for typical knee impairments (effusion, knee motion deficits, lower extremity muscle weakness, and gait deviations) as well as advanced rehabilitation interventions as indicated (jump and agility exercises)
13
Total27

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicStandard Rehabilitation + Quadriceps Intensive StrengtheningTotalStandard Rehabilitation
Age, Continuous18.3 years
STANDARD_DEVIATION 2.8
20.4 years
STANDARD_DEVIATION 4
22.5 years
STANDARD_DEVIATION 5.2
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants4 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants23 Participants11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Height180.1 cm
STANDARD_DEVIATION 8.8
178.5 cm
STANDARD_DEVIATION 8.7
176.9 cm
STANDARD_DEVIATION 8.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants5 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
9 Participants21 Participants12 Participants
Sex: Female, Male
Female
1 Participants3 Participants2 Participants
Sex: Female, Male
Male
12 Participants24 Participants12 Participants
Weight100.9 kg
STANDARD_DEVIATION 30.1
89.8 kg
STANDARD_DEVIATION 26.7
78.7 kg
STANDARD_DEVIATION 13.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 140 / 13
serious
Total, serious adverse events
0 / 140 / 13

Outcome results

Primary

Change in International Knee Documentation Committee (IKDC) Subjective Knee Form Score

The IKDC is a measure of self-reported knee function and includes items related to symptoms and functional activity. Responses on the IKDC subjective knee form will be recorded on hard-copy and the summary score computed. The highest (best) possible score is 100 points and the lowest (worst) possible score is 0 points.

Time frame: Baseline (pre-surgery) to 7 weeks post-surgery (post-intervention)

Population: 2 subjects in the Standard Rehabilitation group did not complete the intervention or post-treatment testing.

ArmMeasureValue (MEAN)Dispersion
Standard RehabilitationChange in International Knee Documentation Committee (IKDC) Subjective Knee Form Score22.2 units on a scaleStandard Deviation 21.6
Standard Rehabilitation + Quadriceps Intensive StrengtheningChange in International Knee Documentation Committee (IKDC) Subjective Knee Form Score20.6 units on a scaleStandard Deviation 21.1
Primary

Change in Tibial Articular Cartilage Volume

A magnetic resonance image (MRI) of the knee will be acquired and software will be used to quantify tibial articular cartilage volume.

Time frame: Baseline (pre-surgery) to 1 year post-surgery

Population: 2 subjects in the Standard Rehabilitation group did not complete the intervention or post-treatment testing. Images were not analyzable for one subject in the Standard+Quadriceps Intensive Strengthening group.

ArmMeasureValue (MEAN)Dispersion
Standard RehabilitationChange in Tibial Articular Cartilage Volume0.18 percentage change from baselineStandard Deviation 3.21
Standard Rehabilitation + Quadriceps Intensive StrengtheningChange in Tibial Articular Cartilage Volume-1.24 percentage change from baselineStandard Deviation 4.27
Secondary

Change in Urinary Concentrations of C-terminal Crosslinking Telopeptide of Type II Collagen (CTX-II)

CTX-II is a biomarker of Type II collagen degradation. Early-morning, second void, fasting urine samples will be collected and stored. Concentrations of CTX-II will be determined with enzyme-linked immunosorbent assay, corrected for creatine concentration, and log-transformed. Creatinine concentration will also be determined with enzyme-linked immunosorbent assay.

Time frame: Baseline (pre-surgery) to 7 weeks post-surgery (post-intervention)

Population: 2 subjects in the Standard Rehabilitation group did not complete the intervention or post-treatment testing.

ArmMeasureValue (MEAN)Dispersion
Standard RehabilitationChange in Urinary Concentrations of C-terminal Crosslinking Telopeptide of Type II Collagen (CTX-II)0.01 log (ng/mmol)Standard Deviation 0.18
Standard Rehabilitation + Quadriceps Intensive StrengtheningChange in Urinary Concentrations of C-terminal Crosslinking Telopeptide of Type II Collagen (CTX-II)-0.11 log (ng/mmol)Standard Deviation 0.13
Secondary

Single Leg Forward Hop Index

Three trials of the single leg forward hop will be collected on each side. Distance will be averaged across trials. The single leg hop index will be computed as \[(distance on the surgical side/distance on the non-surgical side) \*100\]

Time frame: 7 weeks post-surgery (post-intervention)

Population: 2 subjects in the Standard Rehabilitation group did not complete the intervention or post-treatment testing. 2 subjects in the Standard Rehabilitation group and 1 subject in the Standard + Quadriceps Intensive Strengthening group did not complete hop testing.

ArmMeasureValue (MEAN)Dispersion
Standard RehabilitationSingle Leg Forward Hop Index87.1 percentageStandard Deviation 15.2
Standard Rehabilitation + Quadriceps Intensive StrengtheningSingle Leg Forward Hop Index90.1 percentageStandard Deviation 10.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026